{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:21:21Z","timestamp":1759742481234},"reference-count":11,"publisher":"Hindawi Limited","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3217,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01219.x","type":"journal-article","created":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T11:24:25Z","timestamp":1163157865000},"page":"1522-1523","source":"Crossref","is-referenced-by-count":4,"title":["Exenatide and pramlintide: new therapies for diabetes"],"prefix":"10.1155","volume":"60","author":[{"given":"L. L.","family":"Want","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2006,11,10]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/diacare.28.3.632","article-title":"Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes","volume":"28","author":"Ceriello","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1742-1241.2006.01187.x","article-title":"Pramlintide in the treatment of diabetes","volume":"60","author":"Edelman","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB4|cit4","unstructured":"[Symlin] Amylin Pharmaceuticals, Inc. 2005 http:\/\/www.symlin.com\/pdf\/SYMLIN-pi-combined.pdf"},{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/diaclin.20.3.137","article-title":"Amylin replacement with pramlintide in type 1 and type 2 diabetes: a physiological approach to overcome barriers with insulin therapy","volume":"20","author":"Buse","year":"2002","journal-title":"Clin Diabetes"},{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2005-837662","article-title":"Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets","volume":"113","author":"Ratner","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/j.1742-1241.2006.01196.x","article-title":"Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study data","volume":"60","author":"Gallwitz","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/dia.2005.7.467","article-title":"Exenatide improves glycemic control and reduces body weight in subjects with type 2 diabetes: a dose-ranging study","volume":"7","author":"Poon","year":"2005","journal-title":"Diabetes Technol Ther"},{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB9|cit9","unstructured":"[Byetta] Amylin Pharmaceuticals, Inc. 2006 http:\/\/pi.lilly.com\/us\/byetta-pi.pdf"},{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00125-005-1732-4","article-title":"Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes","volume":"48","author":"Chapman","year":"2005","journal-title":"Diabetologia"},{"key":"10.1111\/j.1742-1241.2006.01219.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1210\/en.2003-0323","article-title":"Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets","volume":"144","author":"Farilla","year":"2003","journal-title":"Endocrinology"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01219.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01219.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:04:42Z","timestamp":1643349882000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01219.x"}},"subtitle":["EDITORIALS"],"short-title":[],"issued":{"date-parts":[[2006,11,10]]},"references-count":11,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01219.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11,10]]}}}